Cooper BioPharma Consulting, LLC

Strategic Scientific Leadership from Discovery to Approval

Medicinal Chemistry & Early Discovery

Hands-on drug design and optimization guidance

Innovative approaches to advance your candidates

Tailored strategies to fit your pipeline needs

Preclinical Development & Translational Strategy

CMC/Drug Substance Development

Cooper BioPharma Consulting provides high-level scientific, strategic, and operational expertise to biotechnology, pharmaceutical, and global health organizations. Led by Christopher B. Cooper, PhD, a seasoned R&D executive with more than 35 years of experience across Pfizer, Bristol-Myers Squibb, and the Global Alliance for TB Drug Development (TB Alliance), the firm delivers practical, evidence-based solutions that accelerate drug discovery and development.

Whether your team is advancing a clinical candidate, navigating IND-enabling studies, evaluating partnerships, or building a portfolio from the ground up, Cooper BioPharma Consulting brings the specialized insight needed to move programs forward with confidence.